Loading field map
Since the mid-twentieth century, theriogenology—the branch of veterinary science concerned with animal reproduction—has been pulled between two impulses. One is to understand the intricate mechanisms of reproductive physiology; the other is to control those mechanisms for human purposes. Should theriogenologists focus on diagnosing and explaining reproductive events, or on intervening to manipulate them? And when they intervene, should the goal be the health of an individual animal, the genetic improvement of a herd, or the conservation of an endangered species? Over the past seventy years, four major frameworks have emerged, each offering a different answer to these questions. They have not replaced one another; instead, they have accumulated, creating a pluralist field in which practitioners choose their framework according to the species, the setting, and the problem at hand.
The first framework to define theriogenology as a distinct specialty was Clinical Reproductive Physiology. Before the 1950s, veterinary approaches to reproduction were largely empirical—based on practical experience with breeding and calving rather than on systematic physiological knowledge. Clinical Reproductive Physiology changed that by insisting that the veterinarian must understand the hormonal cycles, ovarian dynamics, and uterine environments that underlie normal and abnormal reproduction. Its signature method was the clinical application of endocrinology: measuring progesterone levels, tracking follicular development via palpation and later ultrasound, and timing interventions to the precise stage of the estrous cycle.
This framework built the infrastructure on which all later frameworks depend. Without the detailed physiological maps it produced—the estrous cycle of the cow, the hormonal control of parturition in the mare, the endocrinology of pregnancy in the bitch—the more interventionist approaches that followed would have had no reliable target. Clinical Reproductive Physiology remains active today as the diagnostic backbone of theriogenology. Every practitioner, regardless of which framework they primarily use, still relies on its methods to assess reproductive status before deciding whether or how to intervene.
By the 1970s, the physiological knowledge accumulated by the first framework began to be turned toward a new goal: not just understanding reproduction but actively controlling it. Reproductive Biotechnology emerged as a framework that absorbed the endocrinological and clinical tools of its predecessor and redirected them toward genetic gain and production efficiency. Its landmark techniques—artificial insemination, embryo transfer, in vitro fertilization, and later cloning and gene editing—all depend on the physiological timing and hormonal protocols that Clinical Reproductive Physiology had established.
Where the earlier framework had been primarily diagnostic, Reproductive Biotechnology was unapologetically interventionist. Its practitioners saw theriogenology as a tool for accelerating genetic improvement in livestock, overcoming infertility in valuable individuals, and even preserving genetics from deceased or distant animals. This created a lasting tension with the health-oriented traditions of veterinary medicine. Critics within the field argued that biotechnology sometimes prioritized genetic gain over animal welfare—for example, by subjecting donor animals to repeated superovulation protocols. Proponents countered that the same techniques could be used to rescue endangered genetics or to study fundamental reproductive mechanisms. The framework did not replace Clinical Reproductive Physiology; it layered an interventionist agenda on top of it, and the two have coexisted in a productive but uneasy partnership ever since.
A decade later, a third framework shifted the unit of analysis from the individual animal to the herd. Population Reproductive Management emerged in the 1980s, borrowing concepts from Herd Health Management and Veterinary Epidemiology—two frameworks already established in the broader discipline of veterinary science. Where Clinical Reproductive Physiology asked "What is happening in this animal's reproductive tract?" and Reproductive Biotechnology asked "How can we manipulate this animal's reproduction?", Population Reproductive Management asked "How is this herd performing reproductively, and what management changes would improve its overall output?"
This framework narrowed theriogenology's focus in two important ways. First, it concentrated almost entirely on production species—dairy cattle, beef cattle, swine, and small ruminants—because those were the species for which herd-level metrics made economic sense. Second, it redefined reproductive success in terms of efficiency: calving interval, conception rate, days open, and similar benchmarks became the primary endpoints. The veterinarian's role shifted from clinician to consultant, analyzing records and recommending management changes rather than performing individual examinations or procedures.
Population Reproductive Management did not compete directly with Reproductive Biotechnology; the two frameworks often complemented each other. A herd veterinarian might use biotechnological tools (timed artificial insemination protocols, for example) within a population-management framework. But their underlying assumptions differed. Biotechnology assumed that the key to better reproduction was better technology; population management assumed that the key was better systems—nutrition, housing, heat detection, record-keeping. This disagreement over whether technical fixes or managerial fixes should take priority remains one of the field's liveliest debates.
The most recent framework, Comparative Reproductive Biology, emerged in the 1990s as a response to the increasing specialization of the earlier frameworks. By focusing on individual physiology, genetic manipulation, or herd performance, theriogenology had become fragmented by species and by goal. Comparative Reproductive Biology revived an older tradition—the comparative anatomy and physiology of the nineteenth century—but at a higher level of generality. Instead of comparing reproductive structures across species, it compared the underlying mechanisms: the molecular pathways that regulate gamete maturation, the evolutionary trade-offs between litter size and offspring investment, the phylogenetic distribution of reproductive strategies.
This framework broadened theriogenology's scope beyond domestic animals to include wildlife, laboratory species, and even humans. It connected theriogenology to conservation medicine and to the One Health and One Medicine frameworks that were gaining traction in the broader veterinary discipline. A comparative reproductive biologist might study why some species are prone to reproductive cancers, how climate change affects breeding seasons in wild populations, or whether assisted reproductive techniques developed for cattle can be adapted for endangered rhinos. The framework did not replace the earlier three; rather, it provided a unifying intellectual context in which their findings could be reinterpreted. Clinical Reproductive Physiology supplied the mechanistic details; Reproductive Biotechnology supplied the tools; Population Reproductive Management supplied the systems perspective; Comparative Reproductive Biology supplied the evolutionary and ecological framework that made sense of them all.
Today, all four frameworks remain active, and their coexistence defines theriogenology as a pluralist field. Clinical Reproductive Physiology dominates in academic veterinary hospitals and specialty practices, where the goal is to diagnose and treat individual infertility cases. Reproductive Biotechnology leads in the livestock breeding industry, where genetic progress is the primary driver. Population Reproductive Management is the default framework in production-animal practice, especially in dairy and swine operations where economic margins are tight. Comparative Reproductive Biology is most visible in conservation programs, zoological medicine, and interdisciplinary research settings.
What the frameworks agree on is that reproductive health matters—for animal welfare, for food security, for biodiversity, and for the human-animal bond. What they disagree on is what counts as a reproductive problem and what counts as a solution. Is infertility a physiological dysfunction to be diagnosed (Clinical Reproductive Physiology), a genetic limitation to be overcome (Reproductive Biotechnology), a management failure to be corrected (Population Reproductive Management), or an evolutionary trade-off to be understood (Comparative Reproductive Biology)? The answer depends on the framework the practitioner adopts, and the best practitioners are those who can move between frameworks as the situation demands. The history of theriogenology is not a story of one framework triumphing over others; it is a story of successive frameworks adding layers of complexity, each revealing new questions that the earlier ones had not asked.